Media
Interviews and Media Mention of Research
CNBC
by Annika Kim Constantino
Wired
RFK Jr. wants to reshape US health policy. Good luck with that (October 31, 2024)
by Emily Mullin and Matt Reynolds
STAT and The Examination
Former FDA lawyers join tobacco industry in ‘epic’ fight against the agency (October 21, 2024)
by Kathryn Kranhold
Wall Street Journal
by Dylan Tokar
Biospace
Patient assistance programs: a source of real-world data? (July 8, 2024)
by Patience Asanga
BioSpace
by Heather McKenzie
STAT News
by Brittany Trang
The Hill
Florida scores drug import win — but many hurdles remain (January 6, 2024)
by Nathaniel Weixel
Forbes
by Katie Jennings
New York Times
Doctors wrestle with A.I. in patient care, citing lax oversight (October 30, 2023)
by Christina Jewett
Fierce Pharma podcast (Audio)
Interview with Kevin Dunleavy
BioSpace
Upcoming NurOwn adcomm highlights regulatory role for patient advocates (September 25, 2023)
by Heather McKenzie
Axios
1 in 3 HHS appointees leave for industry jobs, study finds (September 6, 2023)
by Jason Milliman
STAT News
How a ‘weighted lottery’ helped underserved patients get a scarce Covid drug (September 1, 2023)
by Usha Lee McFarling
Washington Post
by Yeganeh Torbati
Politico
Who will get the new Alzheimer’s drug? (July 11, 2023)
by Katherine Ellen Foley and David Lim
MedPage Today
by Joyce Frieden
Becker’s Hospital Review
The potential healthcare privacy risks of ChatGPT (July 7, 2023)
by Giles Bruce
Wall Street Journal
by Stephanie Armour
Spectrum News (Video)
by Renee Eng
BioSpace
by Heather McKenzie
STAT
by Bob Herman
Modern Healthcare
Health systems turn to venture capital amid financial challenges (April 17, 2023)
by Gabriel Perna
Managed Healthcare Executive
Oncologist, dispense it thyself (November 11, 2022)
by Deborah Adams Kaplan
Renal & Urology News
Cyberattacks in health care are escalating (November 23, 2022)
by John Schieszer
Calling Bullsh!t Podcast (Audio)
FDA: Is there something rotten here? (October 26, 2022)
Interview with Ty Montague of co:collective
STAT
by Katie Palmer
PolitiFact
Why were the recent COVID-19 booster authorized before human trials were completed? (September 13, 2022)
by Andy Nguyen
STAT
by Ed Silverman
Daily Beast
The new coronavirus wave is shutting schools all over again (December 16, 2021)
by Pilar Melendez
Nature
New FDA chief will face COVID woes and calls for drug-approval reform (November 12, 2021)
by Max Kozlov
Deep Background podcast (Audio)
Getting answers on vaccine boosters (September 22, 2021)
Interview with Noah Feldman
Daily Beast
by Pilar Melendez
Kaiser Health News
by Christina Jewett
FiveThirtyEight
Still unsure about getting the COVID-19 vaccine? Start here (August 11, 2021)
by Kaleigh Rogers
The Intercept
UnitedHealthcare guided Yale's groundbreaking surprise billing story (August 10, 2021)
by Rose Adams
Daily Beast
by Pilar Melendez
STAT
by Ed Silverman
Washington Post
by Rachel Chason
Fortune
by Fred Schulte, Elizabeth Lucas, and Kaiser Health News
NPR All Things Considered
With coronavirus variants on the rise, vaccine companies and FDA pivot (February 10, 2021)
by Sydney Lupkin
Washington Post
The racist history that explains why some communities don't have enough ICU beds (September 16, 2020)
by George Aumoithe
Philadelphia Inquirer
by Kasra Zarei
New York Times
by Edgar Sandoval
Well + Good
by Kara Jillian Brown
STAT
Nearly half of low-income communities have no ICU beds in their area (August 3, 2020)
by Juliet Isselbacher
STAT
by Andrew Joseph and Ed Silverman
Science
by Charles Piller
Becker's Hospital Review
Consolidation of physician practices linked to ACOs, study finds (November 8, 2019)
by Morgan Haefner
Fierce Healthcare
ACOs linked to consolidation of physician practices, study finds (November 5, 2019)
by Joanne Finnegan
Philadelphia Inquirer
by Aubrey Whelan and Sarah Gantz
Proto Magazine
by Linda Teslar
BioPharma Dive
Does Disclosure of Pharma Payments Harm Patient Trust in Doctors? (September 23, 2019)
Q&A with Andrew Dunn
Medscape
Sunshine Act Report: Docs See Nothing Wrong with Taking Payments (August 27, 2019)
by Leigh Page
CMAJ News
by Caroline Mercer
Chicago Tribune (Post-Tribune)
Drug Company Payments to Doctors May Influence Prescription Choices (April 16, 2019)
by Trudy Lieberman
STAT
by Ed Silverman
Medscape
Patients Pay More for Growth Hormone, Suffer Restrictions on Use (April 15, 2019)
by Tara Haelle
MD Magazine
by Patrick Campbell
Wharton Radio: Knowledge@Wharton (Audio)
Why Congress Might Relax Physician Anti-Kickback Rules (March 12, 2019)
Interview with Dan Loney
STAT
by Ed Silverman
NPR
New Court Documents Reveal OxyContin Manufacturer's Marketing Tactics (February 2, 2019)
by Deborah Becker
STAT
by Andrew Joseph
Associated Press
Spinal-cord Stimulators Help Some Patients, Injure Others, part of ICIJ international investigation into medical device safety (November 26, 2018)
by Mitch Weiss and Holbrook Mohr
STAT
by Lev Facher
STAT
by Ike Swetlitz
Marketplace Public Radio (Audio)
Kickbacks or a Helpful Service? Here's Why Pharma is Under Fire (September 21, 2018)
by Mitchell Hartman
Science
by Charles Piller
Observer
by John Bonazzo
Reuters
Doctors who take pharmaceutical money use Twitter to hype drugs (September 11, 2017)
by Ronnie Cohen
Chicago Tribune
Are drug firms paying your doctor? (August 17, 2017)
by Lisa Schencker and Jennifer Smith Richards
Philadelphia Inquirer
Two-thirds of patients are seen by doctors who got industry money (March 16, 2017)
by Tom Avril
Fierce Healthcare
65% of patients see doctors who get paid by drug companies (March 8, 2017)
by Joanne Finnegan
Becker's Hospital Review
by Mackenzie Bean
Modern Healthcare
by Elizabeth Whitman
Modern Healthcare
The FDA's revolving door raises ethical questions (September 27, 2016)
by Elizabeth Whitman
Wall Street Journal
Not every conflict of interest produces the same vote on FDA panels (September 9, 2014)
by Ed Silverman
New York Times
Doctors' Magical Thinking About Conflicts of Interest (September 8, 2014)
by Aaron Carroll